Clinical Trial Update: A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a beta-lactam antibiotic in hospitalized patients with skin and soft tissue infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Soft Tissue Infections

Drugs mentioned

• Beta-Lactam (beta-lactam antibiotic)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Soft Tissue Infections | Phase 2 | Status: COMPLETED